In particular, we focus on the recently discovered role oftanshinones as sensitizing agents of tumor necrosis factor (TNF)-relatedapoptosis-inducing ligand (TRAIL), which has an attractive anticancer potential dueto its cancer cell-selective proapoptotic action but is often limited by thedevelopment of TRAIL-resistance in many human tumors. The gene discussed is TNFSF10; the disease is cancer.